[A Clinical and Genetic Analysis of a Pedigree with Two 46,XY Patients Suffering from 17Alpha-Hydroxylase Deficiency].

Jun Liang,Jie Qiao,Xia Chen,Qing-Qiang Wu,Hao Heng,Tong Zhang,Jia-Jun Zhao,Huai-Dong Song
DOI: https://doi.org/10.3321/j.issn:0578-1426.2008.06.014
2008-01-01
Abstract:OBJECTIVE:To investigate the molecular defects of CYP17A1 gene in a pedigree with two 46,XY patients suffering from 17alpha-hydroxylase deficiency (17-OHD) and explore the steroid biosynthetic difference in carriers of 17-OHD before and after adrenocorticotrophic hormone (ACTH) test.METHODS:Clinical data and hormone profiles were collected from the members of the pedigree. CYP17A1 genotyping was performed in the patients and family members with PCR-direct sequencing. A short ACTH test was evaluated in some cases.RESULTS:The CYP17 genes of the patients were proved to hold a homozygous mutation with a base deletion and a base transversion (TAC/AA) in exon 6, which produced a missense mutation of Tyr-->Lys at codon 329 and changed the open reading frame following this codon. The hormone response of the carriers after ACTH stimulation was abnormal between the patients and normal controls.CONCLUSION:17-OHD in this family was caused by CYP17A1 mutation (TAC329AA); some hormonal response to ACTH stimulation was abnormal in carriers.
What problem does this paper attempt to address?